LEEMOONWON Bio Co., Ltd. (CEO Dr. Moonwon Lee), a biotechnology company specializing in the research and development of pharmaceutical and cosmetic solutions for hair loss, announced that it has successfully registered a Korean patent for its innovative herbal compound, LMW19-A and LMW19-B, designed to promote hair growth by activating follicular stem cells through localized scalp injection.
Building on this achievement, the company has filed individual patent applications with the United States Patent and Trademark Office (USPTO) and completed a PCT (Patent Cooperation Treaty) international application to secure intellectual property protection in major global markets.
The registered Korean patent (Application No. 10-2024-0099925), officially titled “Hair Growth-Promoting Composition via Activation of Follicular Stem Cells,” was granted on October 13, 2025. The composition utilizes active ingredients derived from traditional herbal medicines—such as Gardenia jasminoides, Lonicera japonica, Rehmannia glutinosa, Drynaria fortunei, and Angelica gigas—which have been scientifically proven to enhance hair follicle regeneration and growth.
Follicular stem cells play a central role in producing new hair and regenerating damaged tissue throughout the hair cycle. Hair loss occurs when these cells lose their regenerative capacity. Experimental results demonstrated that LMW19-A and LMW19-B can effectively reactivate dormant follicular stem cells, triggering new hair formation.
“The name LMW19 represents the culmination of 19 years of research into hair restoration therapeutics,” said Dr. Moonwon Lee, developer of the patented formula and CEO of LEEMOONWON Bio. “This composition can be locally injected into targeted scalp areas, offering a safe and effective solution for patients concerned about the systemic side effects often associated with oral medications.”
Dr. Lee added, “Both LMW19-A and LMW19-B are extracted from herbs already proven safe for oral use, minimizing the risks linked to synthetic drugs and providing a natural, clinically effective alternative for hair loss treatment.”
About LEEMOONWON Bio
With its domestic and international patents now secured, LEEMOONWON Bio is poised to enter the pharmacopuncture (herbal micro-injection) market, introducing a new paradigm in non-systemic, regenerative hair loss therapy for consumers worldwide.
Media Contact
Company Name: LEEMOONWON BIO Co., Ltd.
Contact Person: LEE MOON WON
Email: Send Email
Country: South Korea
Website: https://eng.leemoonwon.com/
